Henry Schein Inc (NASDAQ: HSIC) reported Q3 FY23 sales of $3.16 billion, slightly missing the consensus of $3.21 billion, up 3.1% Y/Y, including a 1.2% decrease in local currencies excluding acquisitions, reflecting some market softening in the second half of the quarter as well as lower sales of PPE products and COVID-19 test kits.
Growth from acquisitions was 3.2%, and a 1.1% increase in net sales related to foreign currency exchange.
Sales of PPE products and COVID-19 test kits in the quarter were $175 million, a decrease of $69 million versus the prior-year period.
Also Read: Full story available on Benzinga.com